These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2465003)

  • 1. Activation of platelet phospholipase C by fluoride is inhibited by elevation of cyclic AMP.
    Lazarowski ER; Lapetina EG
    Biochem Biophys Res Commun; 1989 Jan; 158(2):440-4. PubMed ID: 2465003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forskolin and prostacyclin inhibit fluoride induced platelet activation and protein kinase C dependent responses.
    Doni MG; Deana R; Bertoncello S; Zoccarato F; Alexandre A
    Biochem Biophys Res Commun; 1988 Nov; 156(3):1316-23. PubMed ID: 2847730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Okadaic acid inhibits activation of phospholipase C in human platelets by mimicking the actions of protein kinases A and C.
    Walker TR; Watson SP
    Br J Pharmacol; 1992 Mar; 105(3):627-31. PubMed ID: 1628149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of synthetic 1,2-diacylglycerol into platelet phosphatidylinositol is increased by cyclic AMP.
    Lapetina EG
    FEBS Lett; 1986 Jan; 195(1-2):111-4. PubMed ID: 3002850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E1 and forskolin antagonize C-kinase activation in the human platelet.
    de Chaffoy de Courcelles D; Roevens P; Van Belle H
    Biochem J; 1987 May; 244(1):93-9. PubMed ID: 2822002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic AMP agonists induce the phosphorylation of phospholipase C-tau and of a 76 kDa protein co-precipitated by anti-(phospholipase C-tau) monoclonal antibodies in BALB/c-3T3 cells. Relationship to inositol phosphate formation.
    Olashaw NE; Rhee SG; Pledger WJ
    Biochem J; 1990 Dec; 272(2):297-303. PubMed ID: 1702622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
    Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of forskolin on platelet deaggregation and cyclic AMP generation.
    Kariya T; Morito F; Sakai T; Takahata K; Yamanaka M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):119-21. PubMed ID: 2999615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostacyclin inhibition of phosphatidic acid synthesis in human platelets is not mediated by protein kinase C.
    Lapetina EG
    Biochem Biophys Res Commun; 1984 Apr; 120(1):37-44. PubMed ID: 6231930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic AMP inhibition of phosphoinositide turnover in human neutrophils.
    Della Bianca V; De Togni P; Grzeskowiak M; Vicentini LM; Di Virgilio F
    Biochim Biophys Acta; 1986 May; 886(3):441-7. PubMed ID: 3011119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of cyclic AMP decreases phosphoinositide turnover and inhibits thrombin-induced secretion in human platelets.
    Ryningen A; Olav Jensen B; Holmsen H
    Biochim Biophys Acta; 1998 Nov; 1394(2-3):235-48. PubMed ID: 9795233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin.
    Schafer AI; Maas AK; Ware JA; Johnson PC; Rittenhouse SE; Salzman EW
    J Clin Invest; 1986 Jul; 78(1):73-9. PubMed ID: 3013942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of platelet protein kinase C activation by cyclic AMP.
    Kroll MH; Zavoico GB; Schafer AI
    Biochim Biophys Acta; 1988 Jun; 970(1):61-7. PubMed ID: 2835990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leupeptin selectively inhibits human platelet responses induced by thrombin and trypsin; a role for proteolytic activation of phospholipase C.
    Ruggiero M; Lapetina EG
    Biochem Biophys Res Commun; 1985 Sep; 131(3):1198-205. PubMed ID: 4052085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol-specific phospholipase-C of platelets: association with 1,2-diacyglycerol-kinase and inhibition by cyclic-AMP.
    Billah MM; Lapetina EG; Cuatrecasas P
    Biochem Biophys Res Commun; 1979 Sep; 90(1):92-8. PubMed ID: 227395
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of ethanol-induced platelet activation by agents that elevate cAMP.
    Rubin R; Hoek JB
    Thromb Res; 1990 Jun; 58(6):625-32. PubMed ID: 2166973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP metabolism in cholesterol-rich platelets.
    Sinha AK; Shattil SJ; Colman RW
    J Biol Chem; 1977 May; 252(10):3310-4. PubMed ID: 193833
    [No Abstract]   [Full Text] [Related]  

  • 18. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S; Nakahata N; Ohizumi Y
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism.
    Crutchley DJ; Solomon DE; Conanan LB
    Arterioscler Thromb; 1992 Jun; 12(6):664-70. PubMed ID: 1375507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activation by Ca2+ of platelet phospholipase A2. Effects of dibutyryl cyclic adenosine monophosphate and 8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate.
    Rittenhouse-Simmons S; Deykin D
    Biochim Biophys Acta; 1978 Nov; 543(4):409-22. PubMed ID: 214141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.